vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and PHINIA INC. (PHIN). Click either name above to swap in a different company.
PHINIA INC. is the larger business by last-quarter revenue ($889.0M vs $493.8M, roughly 1.8× Pediatrix Medical Group, Inc.). On growth, PHINIA INC. posted the faster year-over-year revenue change (6.7% vs -1.7%). Over the past eight quarters, PHINIA INC.'s revenue compounded faster (1.5% CAGR vs -0.1%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
PHINIA Inc. is a global automotive technology provider specializing in fuel injection systems, starters, alternators, and hybrid/electric vehicle components. It serves OEMs and aftermarket customers across North America, Europe, Asia Pacific and key markets, covering passenger car, commercial vehicle and industrial mobility segments.
MD vs PHIN — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $889.0M |
| Net Profit | $33.7M | — |
| Gross Margin | — | 21.7% |
| Operating Margin | 9.9% | 7.8% |
| Net Margin | 6.8% | — |
| Revenue YoY | -1.7% | 6.7% |
| Net Profit YoY | 10.5% | — |
| EPS (diluted) | $0.40 | $1.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $493.8M | $889.0M | ||
| Q3 25 | $492.9M | $908.0M | ||
| Q2 25 | $468.8M | $890.0M | ||
| Q1 25 | $458.4M | $796.0M | ||
| Q4 24 | $502.4M | $833.0M | ||
| Q3 24 | $511.2M | $839.0M | ||
| Q2 24 | $504.3M | $868.0M | ||
| Q1 24 | $495.1M | $863.0M |
| Q4 25 | $33.7M | — | ||
| Q3 25 | $71.7M | $13.0M | ||
| Q2 25 | $39.3M | $46.0M | ||
| Q1 25 | $20.7M | $26.0M | ||
| Q4 24 | $30.5M | — | ||
| Q3 24 | $19.4M | $31.0M | ||
| Q2 24 | $-153.0M | $14.0M | ||
| Q1 24 | $4.0M | $29.0M |
| Q4 25 | — | 21.7% | ||
| Q3 25 | — | 22.0% | ||
| Q2 25 | — | 22.1% | ||
| Q1 25 | — | 21.6% | ||
| Q4 24 | — | 22.7% | ||
| Q3 24 | — | 22.3% | ||
| Q2 24 | — | 21.7% | ||
| Q1 24 | — | 22.2% |
| Q4 25 | 9.9% | 7.8% | ||
| Q3 25 | 13.8% | 3.7% | ||
| Q2 25 | 12.8% | 10.0% | ||
| Q1 25 | 7.0% | 7.8% | ||
| Q4 24 | 7.8% | 6.1% | ||
| Q3 24 | 6.6% | 7.9% | ||
| Q2 24 | -31.3% | 8.2% | ||
| Q1 24 | 3.2% | 8.2% |
| Q4 25 | 6.8% | — | ||
| Q3 25 | 14.5% | 1.4% | ||
| Q2 25 | 8.4% | 5.2% | ||
| Q1 25 | 4.5% | 3.3% | ||
| Q4 24 | 6.1% | — | ||
| Q3 24 | 3.8% | 3.7% | ||
| Q2 24 | -30.3% | 1.6% | ||
| Q1 24 | 0.8% | 3.4% |
| Q4 25 | $0.40 | $1.14 | ||
| Q3 25 | $0.84 | $0.33 | ||
| Q2 25 | $0.46 | $1.14 | ||
| Q1 25 | $0.24 | $0.63 | ||
| Q4 24 | $0.37 | $0.13 | ||
| Q3 24 | $0.23 | $0.70 | ||
| Q2 24 | $-1.84 | $0.31 | ||
| Q1 24 | $0.05 | $0.62 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | $359.0M |
| Total DebtLower is stronger | $570.5M | $970.0M |
| Stockholders' EquityBook value | $865.9M | $1.6B |
| Total Assets | $2.2B | $3.8B |
| Debt / EquityLower = less leverage | 0.66× | 0.61× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $375.2M | $359.0M | ||
| Q3 25 | $340.1M | $349.0M | ||
| Q2 25 | $224.7M | $347.0M | ||
| Q1 25 | $99.0M | $373.0M | ||
| Q4 24 | $229.9M | $484.0M | ||
| Q3 24 | $103.8M | $477.0M | ||
| Q2 24 | $19.4M | $339.0M | ||
| Q1 24 | $8.0M | $325.0M |
| Q4 25 | $570.5M | $970.0M | ||
| Q3 25 | $577.2M | $990.0M | ||
| Q2 25 | $583.9M | $990.0M | ||
| Q1 25 | $590.5M | $989.0M | ||
| Q4 24 | $597.1M | $988.0M | ||
| Q3 24 | — | $987.0M | ||
| Q2 24 | — | $821.0M | ||
| Q1 24 | — | $706.0M |
| Q4 25 | $865.9M | $1.6B | ||
| Q3 25 | $890.7M | $1.6B | ||
| Q2 25 | $833.8M | $1.6B | ||
| Q1 25 | $789.2M | $1.5B | ||
| Q4 24 | $764.9M | $1.6B | ||
| Q3 24 | $732.5M | $1.7B | ||
| Q2 24 | $706.5M | $1.7B | ||
| Q1 24 | $856.2M | $1.9B |
| Q4 25 | $2.2B | $3.8B | ||
| Q3 25 | $2.2B | $4.0B | ||
| Q2 25 | $2.1B | $3.9B | ||
| Q1 25 | $2.0B | $3.7B | ||
| Q4 24 | $2.2B | $3.8B | ||
| Q3 24 | $2.1B | $4.0B | ||
| Q2 24 | $2.0B | $3.9B | ||
| Q1 24 | $2.2B | $4.0B |
| Q4 25 | 0.66× | 0.61× | ||
| Q3 25 | 0.65× | 0.62× | ||
| Q2 25 | 0.70× | 0.61× | ||
| Q1 25 | 0.75× | 0.64× | ||
| Q4 24 | 0.78× | 0.63× | ||
| Q3 24 | — | 0.58× | ||
| Q2 24 | — | 0.47× | ||
| Q1 24 | — | 0.38× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | $96.0M |
| Free Cash FlowOCF − Capex | — | $67.0M |
| FCF MarginFCF / Revenue | — | 7.5% |
| Capex IntensityCapex / Revenue | — | 3.3% |
| Cash ConversionOCF / Net Profit | 3.39× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $188.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.1M | $96.0M | ||
| Q3 25 | $137.3M | $119.0M | ||
| Q2 25 | $137.2M | $57.0M | ||
| Q1 25 | $-117.5M | $40.0M | ||
| Q4 24 | $133.0M | $73.0M | ||
| Q3 24 | $91.8M | $95.0M | ||
| Q2 24 | $107.0M | $109.0M | ||
| Q1 24 | $-125.2M | $31.0M |
| Q4 25 | — | $67.0M | ||
| Q3 25 | — | $93.0M | ||
| Q2 25 | — | $23.0M | ||
| Q1 25 | — | $5.0M | ||
| Q4 24 | — | $53.0M | ||
| Q3 24 | — | $70.0M | ||
| Q2 24 | — | $92.0M | ||
| Q1 24 | — | $-12.0M |
| Q4 25 | — | 7.5% | ||
| Q3 25 | — | 10.2% | ||
| Q2 25 | — | 2.6% | ||
| Q1 25 | — | 0.6% | ||
| Q4 24 | — | 6.4% | ||
| Q3 24 | — | 8.3% | ||
| Q2 24 | — | 10.6% | ||
| Q1 24 | — | -1.4% |
| Q4 25 | — | 3.3% | ||
| Q3 25 | — | 2.9% | ||
| Q2 25 | — | 3.8% | ||
| Q1 25 | — | 4.4% | ||
| Q4 24 | — | 2.4% | ||
| Q3 24 | — | 3.0% | ||
| Q2 24 | — | 2.0% | ||
| Q1 24 | — | 5.0% |
| Q4 25 | 3.39× | — | ||
| Q3 25 | 1.91× | 9.15× | ||
| Q2 25 | 3.49× | 1.24× | ||
| Q1 25 | -5.66× | 1.54× | ||
| Q4 24 | 4.36× | — | ||
| Q3 24 | 4.72× | 3.06× | ||
| Q2 24 | — | 7.79× | ||
| Q1 24 | -31.03× | 1.07× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
PHIN
| Customer | $618.0M | 70% |
| Fuel Systems | $194.0M | 22% |
| Other | $77.0M | 9% |
